Blockage of TNF-α, by anti-TNF-α humanized monoclonal antibodies (Mabs), such as Infliximab Etanercept and Adalimumab, which bind with high affinity to TNF-α, has been shown to successfully treat psoriasis [14]. The gene discussed is TNF; the disease is psoriasis.